Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities

<p>Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient access, safety, […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/comera-life-sciences-announces-publication-of-study-reinforcing-caffeines-viscosity-reducing-capabilities/">Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>